Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432

Updated on: July 31,2024 0

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432

Updated on:July 31,2024 0

The dirty business of beauty | DW Documentary

Updated on: September 05,2024 0

The dirty business of beauty | DW Documentary

Updated on:September 05,2024 0

10 Signs Your Body Is Begging for Vitamin D

Updated on: July 24,2024 0

10 Signs Your Body Is Begging for Vitamin D

Updated on:July 24,2024 0

Marine cyanobacteria in the origin of anti-inflammatory molecules with dermatological, cosmetic applications

by CIIMAR - Interdisciplinary Centre of Marine and Environmental ResearchCredit:Algal Research(2024). DOI: 10.1016/j.algal.2024.103729Inflammation is a biological process through which our

Updated on: January 20,2025 0

Marine cyanobacteria in the origin of anti-inflammatory molecules with dermatological, cosmetic applications

by CIIMAR - Interdisciplinary Centre of Marine and Environmental ResearchCredit:Algal Research(2024). DOI: 10.1016/j.algal.2024.103729Inflammation is a biological process through which our

Updated on:January 20,2025 0

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Updated on: June 25,2024 8

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Updated on:June 25,2024 8

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev

Updated on: June 01,2024 6

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev

Updated on:June 01,2024 6

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

Updated on: July 17,2024 0

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

Updated on:July 17,2024 0

Self-guided online treatment can help with atopic eczema

byKarolinska InstitutetHuman skin structure. Credit: WikipediaA new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as psycholog

Updated on: January 10,2025 0

Self-guided online treatment can help with atopic eczema

byKarolinska InstitutetHuman skin structure. Credit: WikipediaA new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as psycholog

Updated on:January 10,2025 0

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe

Updated on: September 25,2024 0

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe

Updated on:September 25,2024 0

Confirmatory testing underused for tinea capitis diagnosis

by Lori SolomonConfirmatory laboratory testing is only used in one in five cases of suspected tinea capitis (TC), according to a research letter published in the July issue of theJournal of the

Updated on: June 26,2024 6

Confirmatory testing underused for tinea capitis diagnosis

by Lori SolomonConfirmatory laboratory testing is only used in one in five cases of suspected tinea capitis (TC), according to a research letter published in the July issue of theJournal of the

Updated on:June 26,2024 6

Editorial explores safety, ethics and patient satisfaction of cosmetic dermatology in the digital age

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainDriven by rapid advances in technology and the ever-growing influence of the digital landscape, the art of caring for the p

Updated on: December 10,2024 0

Editorial explores safety, ethics and patient satisfaction of cosmetic dermatology in the digital age

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainDriven by rapid advances in technology and the ever-growing influence of the digital landscape, the art of caring for the p

Updated on:December 10,2024 0

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Updated on: November 13,2024 0

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Updated on:November 13,2024 0